Skip to main content
Erschienen in: Acta Diabetologica 7/2018

02.04.2018 | Original Article

The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy

verfasst von: Junlin Zhang, Yiting Wang, Pramesh Gurung, Tingli Wang, Li Li, Rui Zhang, Hanyu Li, Ruikun Guo, Qianqian Han, Jie Zhang, Song Lei, Fang Liu

Erschienen in: Acta Diabetologica | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims

Glomerular basement membrane (GBM) thickening is considered as one of the earliest detectable pathological features of diabetic nephropathy (DN). However, whether the thickness of GBM will impact the prognosis of DN remains largely unknown. Our aim was to explore the relationship between thickness of GBM and DN progression in patients with type 2 diabetes mellitus (T2DM).

Methods

A total of 118 patients with T2DM and biopsy-proven DN who received follow-up for at least 1 year were recruited. The patients were divided into two groups according to the median (787 nm) of the GBM thickness: Group 1: GBM thickness < 787 nm (n = 59), and Group 2: GBM thickness ≥ 787 nm (n = 59). The GBM width was estimated by the direct GBM measurements as recently modified by Haas. Renal outcomes were defined by progression to ESRD and/or doubling of serum creatinine (D-Cr). The influence of GBM thickness on renal outcomes was assessed using Cox regression.

Results

Compared with the Group 1, patients in Group 2 had more serious renal insufficiency and glomerular lesions. During the follow-up, ESRD occurred in 39.8% of patients, and 8.5% of patients progressed to D-Cr. The univariate analysis indicated the greater width of GBM the higher risk of renal outcomes in T2DM patients with DN (HR [95% CI] = 2.180 [1.246–3.814], p = 0.006). However, the multivariate COX analysis demonstrated that the GBM thickness was not an independent risk factor for progression to ESRD or D-Cr (HR [95% CI] = 0.825 [0.404–1.685], p = 0.597) when adjusting for important clinical variables and pathological findings.

Conclusions

In conclusion, the DN patients with greater width of GBM had relatively poorer renal prognosis, although it did not emerge as an independent indicator of disease progression.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol CJASN 12:2032–2045CrossRefPubMed Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol CJASN 12:2032–2045CrossRefPubMed
2.
Zurück zum Zitat O’Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC (2017) Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, 1986–2015. Clin J Am Soc Nephrol CJASN 12:614–623CrossRefPubMed O’Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC (2017) Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, 1986–2015. Clin J Am Soc Nephrol CJASN 12:614–623CrossRefPubMed
4.
Zurück zum Zitat Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, Li Y, Yeung RO, Wang J, Matsushita K, Coresh J, Zhao MH, Wang H (2016) Trends in chronic kidney disease in China. N Engl J Med 375:905–906CrossRefPubMed Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, Li Y, Yeung RO, Wang J, Matsushita K, Coresh J, Zhao MH, Wang H (2016) Trends in chronic kidney disease in China. N Engl J Med 375:905–906CrossRefPubMed
5.
Zurück zum Zitat Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514–1523CrossRefPubMed Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514–1523CrossRefPubMed
6.
Zurück zum Zitat Motawi TK, Shehata NI, ElNokeety MM, El-Emady YF (2018) Potential serum biomarkers for early detection of diabetic nephropathy. Diabetes Res Clin Pract 136:150–158CrossRefPubMed Motawi TK, Shehata NI, ElNokeety MM, El-Emady YF (2018) Potential serum biomarkers for early detection of diabetic nephropathy. Diabetes Res Clin Pract 136:150–158CrossRefPubMed
7.
Zurück zum Zitat Al-Rubeaan K, Siddiqui K, Al-Ghonaim MA, Youssef AM, Al-Sharqawi AH, AlNaqeb D (2017) Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients. Sci Rep 7:2684CrossRefPubMedPubMedCentral Al-Rubeaan K, Siddiqui K, Al-Ghonaim MA, Youssef AM, Al-Sharqawi AH, AlNaqeb D (2017) Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients. Sci Rep 7:2684CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Peired AJ, Sisti A, Romagnani P (2016) Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence. Stem Cells Int 2016:4798639PubMedPubMedCentral Peired AJ, Sisti A, Romagnani P (2016) Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence. Stem Cells Int 2016:4798639PubMedPubMedCentral
9.
Zurück zum Zitat Doshi SM, Friedman AN (2017) Diagnosis and management of type 2 diabetic kidney disease. Clin J Am Soc Nephrol CJASN 12:1366–1373CrossRefPubMed Doshi SM, Friedman AN (2017) Diagnosis and management of type 2 diabetic kidney disease. Clin J Am Soc Nephrol CJASN 12:1366–1373CrossRefPubMed
11.
Zurück zum Zitat Marshall CB (2016) Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic? Am J Physiol Ren Physiol 311:F831–f843CrossRef Marshall CB (2016) Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic? Am J Physiol Ren Physiol 311:F831–f843CrossRef
12.
Zurück zum Zitat Moriya T, Tanaka K, Moriya R (2000) Glomerular structural changes and structural-functional relationships at early stage of diabetic nephropathy in Japanese type 2 diabetic patients. Med Electron Microsc Off J Clin Electron Microsc Soc Jpn 33:115–122CrossRef Moriya T, Tanaka K, Moriya R (2000) Glomerular structural changes and structural-functional relationships at early stage of diabetic nephropathy in Japanese type 2 diabetic patients. Med Electron Microsc Off J Clin Electron Microsc Soc Jpn 33:115–122CrossRef
13.
Zurück zum Zitat Caramori ML, Parks A, Mauer M (2013) Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol JASN 24:1175–1181CrossRefPubMed Caramori ML, Parks A, Mauer M (2013) Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol JASN 24:1175–1181CrossRefPubMed
16.
Zurück zum Zitat Falk RJ, Scheinman JI, Mauer SM, Michael AF (1983) Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32(Suppl 2):34–39CrossRefPubMed Falk RJ, Scheinman JI, Mauer SM, Michael AF (1983) Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32(Suppl 2):34–39CrossRefPubMed
17.
Zurück zum Zitat Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, Michael AF (1991) Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413–420PubMedPubMedCentral Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, Michael AF (1991) Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413–420PubMedPubMedCentral
18.
Zurück zum Zitat Osterby R, Gundersen HJ (1975) Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia 11:225–229CrossRefPubMed Osterby R, Gundersen HJ (1975) Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia 11:225–229CrossRefPubMed
19.
Zurück zum Zitat Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Investig 99:342–348CrossRefPubMedPubMedCentral Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Investig 99:342–348CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Perrin NE, Torbjornsdotter T, Jaremko GA, Berg UB (2010) Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients. Pediatr Diabetes 11:305–313CrossRefPubMed Perrin NE, Torbjornsdotter T, Jaremko GA, Berg UB (2010) Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients. Pediatr Diabetes 11:305–313CrossRefPubMed
21.
Zurück zum Zitat Pinsker JE, Shank T, Dassau E, Kerr D (2015) Comment on American Diabetes Association. Approaches to glycemic treatment. Section 7. In: Standards of medical care in diabetes-2015. Diabetes care 2015, vol 38(Suppl. 1):S41–S48. Diabetes Care 38:e174CrossRefPubMed Pinsker JE, Shank T, Dassau E, Kerr D (2015) Comment on American Diabetes Association. Approaches to glycemic treatment. Section 7. In: Standards of medical care in diabetes-2015. Diabetes care 2015, vol 38(Suppl. 1):S41–S48. Diabetes Care 38:e174CrossRefPubMed
22.
Zurück zum Zitat An Y, Xu F, Le W, Ge Y, Zhou M, Chen H, Zeng C, Zhang H, Liu Z (2015) Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc 30:257–266 An Y, Xu F, Le W, Ge Y, Zhou M, Chen H, Zeng C, Zhang H, Liu Z (2015) Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc 30:257–266
23.
Zurück zum Zitat Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noel LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol JASN 21:556–563CrossRefPubMed Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noel LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol JASN 21:556–563CrossRefPubMed
24.
Zurück zum Zitat Alkayyali S, Lajer M, Deshmukh H, Ahlqvist E, Colhoun H, Isomaa B, Rossing P, Groop L, Lyssenko V (2013) Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes. Diabetologia 56:323–329CrossRefPubMed Alkayyali S, Lajer M, Deshmukh H, Ahlqvist E, Colhoun H, Isomaa B, Rossing P, Groop L, Lyssenko V (2013) Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes. Diabetologia 56:323–329CrossRefPubMed
25.
Zurück zum Zitat Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Investig 74:1143–1155CrossRefPubMedPubMedCentral Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Investig 74:1143–1155CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M (2002) Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51:506–513CrossRefPubMed Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M (2002) Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51:506–513CrossRefPubMed
27.
Zurück zum Zitat Hayashi H, Karasawa R, Inn H, Saitou T, Ueno M, Nishi S, Suzuki Y, Ogino S, Maruyama Y, Kouda Y et al (1992) An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 41:749–757CrossRefPubMed Hayashi H, Karasawa R, Inn H, Saitou T, Ueno M, Nishi S, Suzuki Y, Ogino S, Maruyama Y, Kouda Y et al (1992) An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 41:749–757CrossRefPubMed
28.
Zurück zum Zitat Fufaa GD, Weil EJ, Lemley KV, Knowler WC, Brosius FC 3rd, Yee B, Mauer M, Nelson RG (2016) Structural predictors of loss of renal function in American Indians with type 2 diabetes. Clin J Am Soc Nephrol CJASN 11:254–261CrossRefPubMed Fufaa GD, Weil EJ, Lemley KV, Knowler WC, Brosius FC 3rd, Yee B, Mauer M, Nelson RG (2016) Structural predictors of loss of renal function in American Indians with type 2 diabetes. Clin J Am Soc Nephrol CJASN 11:254–261CrossRefPubMed
29.
Zurück zum Zitat White KE, Bilous RW (2000) Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol JASN 11:1667–1673PubMed White KE, Bilous RW (2000) Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol JASN 11:1667–1673PubMed
30.
Zurück zum Zitat Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P (2000) Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49:476–484CrossRefPubMed Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P (2000) Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49:476–484CrossRefPubMed
31.
Zurück zum Zitat Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 42:1341–1344CrossRefPubMed Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 42:1341–1344CrossRefPubMed
32.
Zurück zum Zitat Drummond KN, Kramer MS, Suissa S, Levy-Marchal C, Dell’Aniello S, Sinaiko A, Mauer M (2003) Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 52:1818–1824CrossRefPubMed Drummond KN, Kramer MS, Suissa S, Levy-Marchal C, Dell’Aniello S, Sinaiko A, Mauer M (2003) Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 52:1818–1824CrossRefPubMed
33.
Zurück zum Zitat Krolewski AS, Skupien J, Rossing P, Warram JH (2017) Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int 91:1300–1311CrossRefPubMedPubMedCentral Krolewski AS, Skupien J, Rossing P, Warram JH (2017) Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int 91:1300–1311CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Li L, Zhang X, Li Z, Zhang R, Guo R, Yin Q, Yang L, Yue R, Su B, Huang S, Xu H, He C, Liu F (2017) Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. J Diabetes Complic 31:114–121CrossRef Li L, Zhang X, Li Z, Zhang R, Guo R, Yin Q, Yang L, Yue R, Su B, Huang S, Xu H, He C, Liu F (2017) Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. J Diabetes Complic 31:114–121CrossRef
35.
Zurück zum Zitat Moriya T, Tanaka K, Hosaka T, Hirasawa Y, Fujita Y (2008) Renal structure as an indicator for development of albuminuria in normo- and microalbuminuric type 2 diabetic patients. Diabetes Res Clin Pract 82:298–304CrossRefPubMed Moriya T, Tanaka K, Hosaka T, Hirasawa Y, Fujita Y (2008) Renal structure as an indicator for development of albuminuria in normo- and microalbuminuric type 2 diabetic patients. Diabetes Res Clin Pract 82:298–304CrossRefPubMed
36.
Zurück zum Zitat Gambara V, Mecca G, Remuzzi G, Bertani T (1993) Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol JASN 3:1458–1466PubMed Gambara V, Mecca G, Remuzzi G, Bertani T (1993) Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol JASN 3:1458–1466PubMed
37.
Zurück zum Zitat Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH (1993) Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064–1070CrossRefPubMed Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH (1993) Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064–1070CrossRefPubMed
38.
Zurück zum Zitat Guan M, Ma J, Keaton JM, Dimitrov L, Mudgal P, Stromberg M, Bonomo JA, Hicks PJ, Freedman BI, Bowden DW, Ng MC (2016) Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans. Hum Genet 135:1251–1262CrossRefPubMedPubMedCentral Guan M, Ma J, Keaton JM, Dimitrov L, Mudgal P, Stromberg M, Bonomo JA, Hicks PJ, Freedman BI, Bowden DW, Ng MC (2016) Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans. Hum Genet 135:1251–1262CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Chen C, Wang C, Hu C, Han Y, Zhao L, Zhu X, Xiao L, Sun L (2017) Normoalbuminuric diabetic kidney disease. Front Med 11:310–318CrossRefPubMed Chen C, Wang C, Hu C, Han Y, Zhao L, Zhu X, Xiao L, Sun L (2017) Normoalbuminuric diabetic kidney disease. Front Med 11:310–318CrossRefPubMed
40.
Zurück zum Zitat Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY, Panagiotopoulos S, McNeil K, Baker ST, Fioretto P, Macisaac RJ (2013) Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care 36:3620–3626CrossRefPubMedPubMedCentral Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY, Panagiotopoulos S, McNeil K, Baker ST, Fioretto P, Macisaac RJ (2013) Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care 36:3620–3626CrossRefPubMedPubMedCentral
Metadaten
Titel
The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy
verfasst von
Junlin Zhang
Yiting Wang
Pramesh Gurung
Tingli Wang
Li Li
Rui Zhang
Hanyu Li
Ruikun Guo
Qianqian Han
Jie Zhang
Song Lei
Fang Liu
Publikationsdatum
02.04.2018
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 7/2018
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1128-9

Weitere Artikel der Ausgabe 7/2018

Acta Diabetologica 7/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.